JPWO2020241660A1 - - Google Patents
Info
- Publication number
- JPWO2020241660A1 JPWO2020241660A1 JP2021522798A JP2021522798A JPWO2020241660A1 JP WO2020241660 A1 JPWO2020241660 A1 JP WO2020241660A1 JP 2021522798 A JP2021522798 A JP 2021522798A JP 2021522798 A JP2021522798 A JP 2021522798A JP WO2020241660 A1 JPWO2020241660 A1 JP WO2020241660A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019099425 | 2019-05-28 | ||
| JP2019099425 | 2019-05-28 | ||
| PCT/JP2020/020835 WO2020241660A1 (ja) | 2019-05-28 | 2020-05-27 | 糖尿病網膜症の予防又は治療薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2020241660A1 true JPWO2020241660A1 (https=) | 2020-12-03 |
| JP7561433B2 JP7561433B2 (ja) | 2024-10-04 |
Family
ID=73553760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522798A Active JP7561433B2 (ja) | 2019-05-28 | 2020-05-27 | 糖尿病網膜症の予防又は治療薬 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7561433B2 (https=) |
| WO (1) | WO2020241660A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7729583B2 (ja) * | 2021-05-18 | 2025-08-26 | 学校法人順天堂 | 炎症性腸疾患の予防又は治療薬 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007020563A (ja) * | 2005-06-13 | 2007-02-01 | Sutaagen:Kk | 糖尿病網膜症発症及び／又は進展リスクの診断方法 |
| WO2009144933A1 (ja) * | 2008-05-27 | 2009-12-03 | 国立大学法人東京大学 | アポトーシス誘導薬 |
| JP2014503555A (ja) * | 2011-01-13 | 2014-02-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 血管新生眼疾患を処置するためのｖｅｇｆアンタゴニストの使用 |
| JP2016530244A (ja) * | 2013-12-31 | 2016-09-29 | ディベロップメント センター フォー バイオテクノロジーＤｅｖｅｌｏｐｍｅｎｔ Ｃｅｎｔｅｒ Ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ | 抗ｖｅｇｆ抗体及びその使用 |
-
2020
- 2020-05-27 WO PCT/JP2020/020835 patent/WO2020241660A1/ja not_active Ceased
- 2020-05-27 JP JP2021522798A patent/JP7561433B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007020563A (ja) * | 2005-06-13 | 2007-02-01 | Sutaagen:Kk | 糖尿病網膜症発症及び／又は進展リスクの診断方法 |
| WO2009144933A1 (ja) * | 2008-05-27 | 2009-12-03 | 国立大学法人東京大学 | アポトーシス誘導薬 |
| JP2014503555A (ja) * | 2011-01-13 | 2014-02-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 血管新生眼疾患を処置するためのｖｅｇｆアンタゴニストの使用 |
| JP2016530244A (ja) * | 2013-12-31 | 2016-09-29 | ディベロップメント センター フォー バイオテクノロジーＤｅｖｅｌｏｐｍｅｎｔ Ｃｅｎｔｅｒ Ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ | 抗ｖｅｇｆ抗体及びその使用 |
Non-Patent Citations (2)
| Title |
|---|
| SEKO, Y. ET AL.: "Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis", SCIENTIFIC REPORTS, vol. volume 5, Article number: 13737, JPN6020026152, 2015, ISSN: 0005348854 * |
| SUZUKI, Y. ET AL.: "Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing prot", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, vol. 257, JPN6020026154, 6 May 2019 (2019-05-06), pages 1519 - 1525, ISSN: 0005348855 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7561433B2 (ja) | 2024-10-04 |
| WO2020241660A1 (ja) | 2020-12-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220222 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220302 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230515 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20230608 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20230608 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240402 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240513 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240618 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240805 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240910 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240913 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7561433 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |